ECT/Succinylcholine: Biochemical, Serum and Cardiovascular Changes
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00750906 |
Recruitment Status :
Terminated
(Study on hold since 2009. Awaiting FDA approval of Sugammdex to complete second arm of study.)
First Posted : September 11, 2008
Last Update Posted : January 18, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Depression |
Study Type : | Observational |
Actual Enrollment : | 13 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | The Muscle Biochemical, Serum Potassium and Cardiovascular Changes After Succinylcholine in Patients Undergoing Electroconvulsive Therapy. |
Study Start Date : | October 2008 |
Actual Primary Completion Date : | April 30, 2015 |
Actual Study Completion Date : | April 30, 2015 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- A male or non-pregnant female aged 18 years and older
- American Society of Anesthesiologists physical status 1, 2, 3
- Scheduled to undergo electroconvulsive therapy under general anesthesia
- Have given written informed consent
Exclusion Criteria:
- Pregnant or nursing
- Any patient in the study investigators opinion who may not be suitable for research.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00750906
United States, California | |
University of California San Francisco | |
San Francisco, California, United States, 94143 |
Study Director: | Ronald D Miller, MD | University of California, San Francisco |
Responsible Party: | University of California, San Francisco |
ClinicalTrials.gov Identifier: | NCT00750906 |
Other Study ID Numbers: |
H898-32701 |
First Posted: | September 11, 2008 Key Record Dates |
Last Update Posted: | January 18, 2020 |
Last Verified: | January 2020 |
Depression Behavioral Symptoms |